Availability and Reproducibility Evaluation of High-dose-rate Intraluminal Brachytherapy for Unresectable Recurrent Cholangiocarcinoma
![]() |
Park, Ju-Kyeong
(Department of Radiation Oncology, Chonbuk National University Medical School)
Lee, Seung-Hun (Department of Radiation Oncology, Chonbuk National University Medical School) Cha, Seok-Yong (Department of Radiation Oncology, Chonbuk National University Medical School) Kim, Yang-Su (Department of Radiation Oncology, Chonbuk National University Medical School) Lee, Sun-Young (Department of Radiation Oncology, Chonbuk National University Medical School) |
1 | Bruha R, Petrtyl J, Kubecova M, Marecek Z, Dufek V, Urganek P, Kodadova J, Chodounsky Z. Intraluminal brachytherapy and selfexpendable stents in nonresectable biliary malignancies - The question of long term palliation. Hepatogastroenterology. Vol. 48, pp.631-637, 2001. |
2 | Yoon WS, Kim TH, Yang DS, Choi MS, Kim CY. High-dose-rate intraluminal brachytherapy for biliary obstruction by secondary malignant biliary tumors. J The Korean Soc Ther Radiol Oncol, Vol. 21, No. 1, pp.35-43, 2003. |
3 | Lee SG, Lee YJ, Pa가 KM, Hwang S, Min PC. One houndred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg. Vol. 7, pp.135-141, 2000. DOI ScienceOn |
4 | Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberge WMC, Taylor-Robinson SD, Thillaianayagam AV, Thomas HC, Thursz MR, Wasan H. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. Vol. 51(Suppl. 6), VI1-9, 2002. DOI |
5 | Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita Y, Tsujita E, Aishima S. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery. Vol. 131(Suppl 1), S159-164, 2002. DOI ScienceOn |
6 | Sauz-Altamira PM, Ferante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer. Vol. 82, pp.2321-2325, 1998. DOI ScienceOn |
7 | Sagawa N, Kondo S, Morikawa T, Okushiba S, Katoh H. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today. Vol. 35, pp.548-552, 2005. DOI ScienceOn |
8 | Ove R, Kennedy A, Darwin P, Haluszka O. Postoperative endoscopic retrograde high dose rate brachytherapy for cholangiocarcinoma. Am J Clin Oncol. Vol 23, pp.559-561, 2000. DOI ScienceOn |
9 | Lu JJ, Bains YS, Abdel-Wahab M, Brandon AH, Wolfson AH, Raub WA, Wilkinson CM, Markoe AM. High dose rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma. Cancer J. Vol. 8, pp.74-48, 2002. DOI |
10 | Todoroki T. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology. Vol. 47, pp.644-649, 2000. |
11 | Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long term survival after surgery for hilar cholangiocarcinoma? Cancer. Vol. 79, pp.26-34, 1997. DOI ScienceOn |
12 | Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Amano H, Miura F. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas.J Hepatobiliary Pancreat Surg. Vol. 15, no. 1, pp.2-6, 2008. DOI |
![]() |